AIM IMMUNOTECH INC (AIM) Stock Analyst Earnings Estimates
NYSEARCA:AIM - NYSE Arca - US00901B1052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 135K -17.18% | 141K 4.44% | 202K 43.26% | 146.45K -27.50% | 2.626M 1,693.10% | 7.575M 188.46% | 9.848M 30.01% | 51.553M 423.49% | 118.27M 129.41% | 227.59M 92.43% | 312.19M 37.17% | 378.93M 21.38% | |
| EBITDA YoY % growth | -16.284M -14.00% | -19.667M -20.77% | -31.678M -61.07% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -17.059M -13.60% | -19.923M -16.79% | -31.916M -60.20% | -21.096M 33.90% | -24.496M -16.12% | -32.76M -33.74% | -39.398M -20.26% | -8.79M 77.69% | 43.5M 594.88% | 128.74M 195.95% | 194.1M 50.77% | 245.06M 26.25% | |
| Operating Margin | -12,636.30% | -14,129.79% | -15,800.00% | -14,404.83% | -932.81% | -432.48% | -400.06% | -17.05% | 36.78% | 56.57% | 62.17% | 64.67% | |
| EPS YoY % growth | -0.40 20.00% | -0.40 | -0.60 -50.00% | -0.35 41.93% | -0.37 -7.25% | -0.46 -24.32% | -0.54 -15.22% | -0.12 77.36% | 0.59 583.33% | 1.74 196.55% | 2.56 47.09% | 3.11 21.74% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 55.33% | -0.09 24.25% | -0.09 -127.25% | -0.09 -42.03% | -0.09 21.74% |
| Revenue Q2Q % growth | 101K 55.38% | -100.00% | 101K 102.00% | -100.00% | 101K |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.768M 51.67% | -5.656M 1.36% | -5.656M -53.11% | -5.656M -26.00% | -5.656M 16.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.06 60.00% | -0.10 | 0.04 | 36.63% |
| Q2 2024 Q2Q % growth | -0.04 60.00% | -0.12 | 0.08 | 67.89% |
| Q1 2024 Q2Q % growth | -0.12 -50.00% | -0.12 | 0.00 | -3.31% |
| Q4 2023 Q2Q % growth | -0.26 -188.89% | -0.15 | -0.11 | -71.62% |
| Q3 2023 Q2Q % growth | -0.16 -23.08% | -0.11 | -0.05 | -44.01% |
| Q2 2023 Q2Q % growth | -0.10 | -0.11 | 0.01 | 9.99% |
| Q1 2023 Q2Q % growth | -0.08 | -0.11 | 0.03 | 27.99% |
| Q4 2022 Q2Q % growth | -0.09 25.00% | -0.12 | 0.03 | 25.74% |
| Q3 2022 Q2Q % growth | -0.13 -62.50% | -0.09 | -0.04 | -51.43% |
| Q2 2022 Q2Q % growth | -0.10 16.67% | -0.08 | -0.02 | -32.01% |
| Q1 2022 Q2Q % growth | -0.08 | -0.07 | -0.01 | -13.15% |
| Q4 2021 Q2Q % growth | -0.12 -33.33% | -0.09 | -0.03 | -39.78% |
| Q3 2021 Q2Q % growth | -0.08 | -0.08 | 0.00 | -5.61% |
| Q2 2021 Q2Q % growth | -0.12 -9.09% | -0.08 | -0.04 | -42.58% |
| Q1 2021 Q2Q % growth | -0.08 63.64% | -0.09 | 0.01 | 8.61% |
| Q4 2020 Q2Q % growth | -0.09 32.84% | -0.07 | -0.02 | -21.52% |
| Q3 2020 Q2Q % growth | -0.08 92.92% | -0.08 | 0.00 | 4.95% |
| Q2 2020 Q2Q % growth | -0.11 89.72% | -0.10 | -0.01 | -8.91% |
| Q1 2020 Q2Q % growth | -0.22 92.44% | -0.15 | -0.07 | -48.51% |
| Q4 2019 Q2Q % growth | -0.13 | -0.37 | 0.24 | 64.14% |
| Q3 2019 Q2Q % growth | -1.13 | -0.98 | -0.15 | -15.34% |
| Q2 2019 Q2Q % growth | -1.07 | -1.72 | 0.65 | 37.68% |
| Q1 2019 Q2Q % growth | -2.91 | -2.22 | -0.69 | -30.96% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 35K -23.91% | 17.675K | 17.325K | 98.02% |
| Q2 2024 Q2Q % growth | 50K 19.05% | 11.787K | 38.213K | 324.21% |
| Q1 2024 Q2Q % growth | 40K -18.37% | 40K | % | |
| Q4 2023 Q2Q % growth | 65K 16.07% | 36.865K | 28.135K | 76.32% |
| Q3 2023 Q2Q % growth | 46K 119.05% | 17.675K | 28.325K | 160.25% |
| Q2 2023 Q2Q % growth | 42K 40.00% | 23.23K | 18.77K | 80.80% |
| Q1 2023 Q2Q % growth | 49K 48.48% | 49K | % | |
| Q4 2022 Q2Q % growth | 56K 12.00% | 185.507K | -129.507K | -69.81% |
| Q3 2022 Q2Q % growth | 21K -36.36% | 152.843K | -131.843K | -86.26% |
| Q2 2022 Q2Q % growth | 30K -42.31% | 139.047K | -109.047K | -78.42% |
| Q1 2022 Q2Q % growth | 33K 17.86% | 704.475K | -671.475K | -95.32% |
| Q4 2021 Q2Q % growth | 50K 19.05% | 37.037K | 12.963K | 35.00% |
| Q3 2021 Q2Q % growth | 33K -8.33% | 350.47K | -317.47K | -90.58% |
| Q2 2021 Q2Q % growth | 52K 30.00% | 354.51K | -302.51K | -85.33% |
| Q1 2021 Q2Q % growth | 28K -37.78% | 353.167K | -325.167K | -92.07% |
| Q4 2020 Q2Q % growth | 42K -16.00% | 357.207K | -315.207K | -88.24% |
| Q3 2020 Q2Q % growth | 36K -40.98% | 363.6K | -327.6K | -90.10% |
| Q2 2020 Q2Q % growth | 40K 37.93% | 339.027K | -299.027K | -88.20% |
| Q1 2020 Q2Q % growth | 45K | 338.017K | -293.017K | -86.69% |
| Q4 2019 Q2Q % growth | 50K | 462.247K | -412.247K | -89.18% |
| Q3 2019 Q2Q % growth | 61K | 74.235K | -13.235K | -17.83% |
| Q2 2019 Q2Q % growth | 29K | 64.64K | -35.64K | -55.14% |
| Q1 2019 Q2Q % growth | 73.73K | -73.73K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.17% | -4.55% | -2.47% | -2.47% |
| Revenue | 48.15% | N/A | 0% | -3.33% |